Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

TB Alliance Signs China Research Deal

by Ann M. Thayer
April 4, 2011 | A version of this story appeared in Volume 89, Issue 14

The nonprofit Global Alliance for TB Drug Development has signed an agreement with the International Scientific Exchange Foundation of China to discover and develop affordable and fast-acting drugs against tuberculosis. The two organizations will set up the Global Health R&D Center of China to develop treatments for public health diseases, including tuberculosis, malaria, and HIV/AIDS. The partners say GHRC will be the first Chinese not-for-profit product development partnership.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.